A new scientific paper authored by Emanuele Montomoli and Claudia Maria Trombetta has just been published in Expert Review of Vaccines:
“High-dose influenza vaccine: enhanced protection for the elderly.”
The review highlights the added value of the high-dose influenza vaccine, particularly in adults over 65, who experience the highest rates of influenza-related complications.
The work analyzes current evidence on improved immunogenicity, reduction of morbidity, and the role of high-dose formulations in addressing immunosenescence and protecting frail and older adults.
A timely contribution at the beginning of the flu season, reinforcing the importance of targeted vaccination strategies for populations at higher risk.
